IgG1

• Supplier: AbD Serotec
• Catalog: PHP010
• Category: Protein
• Prices: $345.00
• Sizes: 1 mg
• Applications: ELISA FA
• Species Reactivities: Human
• Source: Purified protein prepared from human myeloma serum by ion exchange chromatography, gel filtration and protein A chromatography.
• SwissProt/Accession: P01834
• Gene: IGKC

Product References

Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. - Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.

Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. J Immunol. 2006 Feb 1;176(3):1889-98.

NKp44 receptor mediates interaction of the envelope glycoproteins from the West - NKp44 receptor mediates interaction of the envelope glycoproteins from the West

Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, Gershoni-Yahalom O, Brient-Litzler E, Bedouelle H, Ho JW, Campbell KS, Rager-Zisman B, Despres P, Porgador A. J Immunol. 2009 Aug 15;183(4):2610-21.

Harnessing soluble NK cell killer receptors for the generation of novel cancer - Harnessing soluble NK cell killer receptors for the generation of novel cancer

Arnon TI, Markel G, Bar-Ilan A, Hanna J, Fima E, Benchetrit F, Galili R, Cerwenka A, Benharroch D, Sion-Vardy N, Porgador A, Mandelboim O. PLoS One. 2008 May 14;3(5):e2150.

Mechanism of amyloid removal in patients with Alzheimer disease treated with - Mechanism of amyloid removal in patients with Alzheimer disease treated with

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L. Arch Neurol. 2012 Feb;69(2):198-207.

Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural - Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural

Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, Yossef R, Rosenberg LA, Aharoni A, Cerwenka A, Campbell KS, Braiman A, Porgador A. J Immunol. 2011 Dec 1;187(11):5693-702.

DCIR interacts with ligands from both endogenous and pathogenic origin. - DCIR interacts with ligands from both endogenous and pathogenic origin.

Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, Garcia-Vallejo JJ, van Vliet SJ, van Kooyk Y. Immunol Lett. 2014 Mar-Apr;158(1-2):33-41.